Cite
MLA Citation
Tomoyuki Hida et al.. “Tumor Volume Analysis as a Predictive Marker for Prolonged Survival in Anaplastic Lymphoma Kinase–rearranged Advanced Non–Small Cell Lung Cancer Patients Treated With Crizotinib.” Journal of thoracic imaging, vol. 35, no. 2, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100141228276.0x000043